Difficulty: Medium
Average Score: 93%
Practice
Almost all of the diseases detected in neonatal screening programs have a very low prevalence; the strategy is to use the initial screening test to separate a highly suspect group from normal and then follow this suspect group aggressively. Of the following, the disease that has low prevalence rendering it not useful for neonatal screening testing is
Correct answer
D
Rationale
In the context of pediatric emergency nursing, understanding the rationale behind neonatal screening programs is crucial for identifying diseases with low prevalence that may not be suitable for routine testing. In this scenario, the correct answer is D) neuroblastoma.
Neuroblastoma is a rare cancer that primarily affects infants and young children, making it a disease with very low prevalence in the general population. Due to its rarity, screening all newborns for neuroblastoma would not be practical or cost-effective. Instead, diagnosis of neuroblastoma typically occurs when symptoms or signs of the disease present themselves, leading to further diagnostic testing.
Phenylketonuria (PKU), hypothyroidism, and cystic fibrosis are commonly included in neonatal screening programs due to their higher prevalence and the availability of effective interventions that can significantly improve outcomes when detected early. PKU and hypothyroidism are metabolic disorders that, if left untreated, can lead to serious health complications. Cystic fibrosis, a genetic disorder affecting the lungs and digestive system, also benefits from early detection and intervention to improve quality of life.
Educationally, this question highlights the importance of selecting appropriate diseases for neonatal screening based on prevalence, available treatments, and the impact of early detection on outcomes. It reinforces the need for healthcare providers to prioritize screening for conditions where early intervention can make a significant difference in a child's long-term health and well-being.
Neuroblastoma is a rare cancer that primarily affects infants and young children, making it a disease with very low prevalence in the general population. Due to its rarity, screening all newborns for neuroblastoma would not be practical or cost-effective. Instead, diagnosis of neuroblastoma typically occurs when symptoms or signs of the disease present themselves, leading to further diagnostic testing.
Phenylketonuria (PKU), hypothyroidism, and cystic fibrosis are commonly included in neonatal screening programs due to their higher prevalence and the availability of effective interventions that can significantly improve outcomes when detected early. PKU and hypothyroidism are metabolic disorders that, if left untreated, can lead to serious health complications. Cystic fibrosis, a genetic disorder affecting the lungs and digestive system, also benefits from early detection and intervention to improve quality of life.
Educationally, this question highlights the importance of selecting appropriate diseases for neonatal screening based on prevalence, available treatments, and the impact of early detection on outcomes. It reinforces the need for healthcare providers to prioritize screening for conditions where early intervention can make a significant difference in a child's long-term health and well-being.